These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7645951)

  • 1. 4'-Epi-doxorubicin and hyperthermia in a murine mammary carcinoma: influence of the dose and fractionation.
    Cividalli A; Danesi DT; Altavista P; Bonanni M; Persiani D; Segre L; Cruciani G
    Anticancer Res; 1995; 15(3):739-43. PubMed ID: 7645951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
    Overgaard J; Radacic MM; Grau C
    Cancer Res; 1991 Jan; 51(2):707-11. PubMed ID: 1985787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced therapeutic efficacy of cisplatin by combination with diethyldithiocarbamate and hyperthermia in a mouse model.
    Murthy MS; Rao LN; Khandekar JD; Scanlon EF
    Cancer Res; 1987 Feb; 47(3):774-9. PubMed ID: 3026616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo.
    Overgaard J
    Cancer Res; 1976 Sep; 36(9 pt.1):3077-81. PubMed ID: 975075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of mammary tumors of C3H/He mice to hyperthermia and bleomycin in vivo.
    Ma F; Hiraoka M; Jo S; Akuta K; Nishimura Y; Takahashi M; Abe M
    Radiat Med; 1985; 3(4):230-3. PubMed ID: 2425397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Horsman MR
    Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.
    Hokland SL; Horsman MR
    Int J Hyperthermia; 2007 Nov; 23(7):599-606. PubMed ID: 18038290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermia and paclitaxel--epirubicin chemotherapy: enhanced cytotoxic effect in a murine mammary adenocarcinoma.
    Cividalli A; Livdi E; Ceciarelli F; Piscitelli M; Pasqualetti P; Cruciani G; Danesi DT
    Int J Hyperthermia; 2000; 16(1):61-71. PubMed ID: 10669317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of epirubicin hydrochloride (EPI) plus pretreatment of medroxyprogesterone acetate (MPA) on FM3A breast cancer cells transplanted in female C3H/He mice.
    Yuyama Y; Yagihashi A; Hirata K; Suzuki Y; Ohmura T; Okazaki M; Watanabe N
    In Vivo; 2003; 17(3):251-4. PubMed ID: 12929575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2).
    Jürgenliemk-Schulz IM; Renes IB; Rutgers DH; Everse LA; Bernsen MR; Den Otter W; Battermann JJ
    Radiat Oncol Investig; 1997; 5(2):54-61. PubMed ID: 9303058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.
    Huang SK; Stauffer PR; Hong K; Guo JW; Phillips TL; Huang A; Papahadjopoulos D
    Cancer Res; 1994 Apr; 54(8):2186-91. PubMed ID: 8174126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological changes in transplanted mouse mammary carcinoma following hyperthermia with or without radiation.
    Jo S; Hiraoka M; Akuta K; Nishimura Y; Furuta M; Takahashi M; Abe M
    Jpn J Cancer Res; 1986 Nov; 77(11):1095-101. PubMed ID: 3098719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
    Jordan A; Scholz R; Wust P; Fähling H; Krause J; Wlodarczyk W; Sander B; Vogl T; Felix R
    Int J Hyperthermia; 1997; 13(6):587-605. PubMed ID: 9421741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequencing of combined hyperthermia and photodynamic therapy.
    Chen Q; Chen H; Shapiro H; Hetzel FW
    Radiat Res; 1996 Sep; 146(3):293-7. PubMed ID: 8752307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
    Kozin SV; Kozina LV
    Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
    Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
    Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermia and liposomal encapsulated doxorubicin.
    Ben-Yosef R; Gipps M; Zeira M
    Isr Med Assoc J; 2003 Jun; 5(6):407-9. PubMed ID: 12841010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between RSU-1069, hydralazine and hyperthermia in a C3H mammary carcinoma as assessed by tumour growth delay.
    Horsman MR; Overgaard J; Chaplin DJ
    Acta Oncol; 1988; 27(6b):861-2. PubMed ID: 3233175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.